Hanmi awarded patent prize from KIPO

Published: 2003-12-24 06:58:00

Updated: 2003-12-24 06:58:00

Hanmi Pharm said that it received a Choongmugong Award from the Korean Intellectual Property Office on December 19 in recognition of its successful development for novel antihypertensive amlodipine camsylate, improved chemical entity with better stability after intensive three-year studies.

Officials from the KIPO said that the reaction yield of amlodipine camsylate, a new imidazole derivati...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.